Your browser doesn't support javascript.
loading
Inhibition of the AKT/mTOR Pathway Augments the Anticancer Effects of Sorafenib in Thyroid Cancer.
Yi, Heqing; Ye, Xuemei; Long, Bin; Ye, Ting; Zhang, Lijun; Yan, Fengqin; Yang, Yang; Li, Linfa.
Affiliation
  • Yi H; 1 Department of Nuclear Medicine, Zhejiang Cancer Hospital , Hangzhou, People's Republic of China .
  • Ye X; 1 Department of Nuclear Medicine, Zhejiang Cancer Hospital , Hangzhou, People's Republic of China .
  • Long B; 1 Department of Nuclear Medicine, Zhejiang Cancer Hospital , Hangzhou, People's Republic of China .
  • Ye T; 1 Department of Nuclear Medicine, Zhejiang Cancer Hospital , Hangzhou, People's Republic of China .
  • Zhang L; 1 Department of Nuclear Medicine, Zhejiang Cancer Hospital , Hangzhou, People's Republic of China .
  • Yan F; 2 Department of Radiation Oncology, Zhejiang Cancer Hospital , Hangzhou, People's Republic of China .
  • Yang Y; 2 Department of Radiation Oncology, Zhejiang Cancer Hospital , Hangzhou, People's Republic of China .
  • Li L; 1 Department of Nuclear Medicine, Zhejiang Cancer Hospital , Hangzhou, People's Republic of China .
Cancer Biother Radiopharm ; 32(5): 176-183, 2017 Jun.
Article in En | MEDLINE | ID: mdl-28622037

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Phenylurea Compounds / Thyroid Neoplasms / Niacinamide / Proto-Oncogene Proteins c-akt / TOR Serine-Threonine Kinases / Antineoplastic Agents Language: En Journal: Cancer Biother Radiopharm Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Phenylurea Compounds / Thyroid Neoplasms / Niacinamide / Proto-Oncogene Proteins c-akt / TOR Serine-Threonine Kinases / Antineoplastic Agents Language: En Journal: Cancer Biother Radiopharm Year: 2017 Type: Article